Autopsy report · NCT00753623

Clinical Management of Neuropathic Pain With Ramelteon

“Recruitment did not accrue as expected.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 3 months before it stopped.
• 23 participants enrolled.
• Results were posted on the registry 2 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Neuropathic Pain

Interventions

Ramelteon; Placebo

Participants

23

Sites

1

Countries

United States

Trials that died the same way

• Endoscopic Gastric Plication for Weight Loss in Morbidly Obese Patients Prior to Incisional Hernia Repair
  “Did not receive funding for recruitment.” (81% match in meaning)
• Early Administration of the Lutein/Zeaxanthin in Premature Newborns
  “Recruitment was not possible” (77% match in meaning)
• Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
  “recruiting subjects did not start.” (77% match in meaning)
• Contraception Navigator Program
  “Target recruitment was not achieved prior to funding end.” (76% match in meaning)
• High-intensity Exercise After Acute Cardiac Event (HITCARE)
  “Recruitment was stopped due to lack of funding.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.